SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DMTC or DIAMOND The Cat Coin is a viral meme coin on Solana Blockchain, Based in Thailand and Global and Based on a true story about my lovely cat(DIAMOND) and made by love, I just want my cat to be immortal in this whole world until I die that's a first idea of this project start. We're start from $2,000 Market cap and hit All time high at $10.9 million, please come to check our project and let's DMTC get list on Coingecko to let's everyone in this whole world know DMTC.

DIAMOND The Cat Coin

DIAMOND The Cat Coin ($DMTC.X) is gaining attention as traders discuss its potential for a significant surge, pointing to chart signals and strong buy walls. The community emphasizes accumulating positions, suggesting a "quiet before the storm" scenario, with many referencing "rocket" and "moon" analogies implying strong upward momentum. Some users are warning of a potential rug pull.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community rallies behind its Bitcoin-native status and fair distribution, contrasting it with other meme coins. The community emphasizes its strong foundation and potential for significant growth as the leading meme coin on the Bitcoin blockchain. Discussions highlight the mission to onboard millions to Bitcoin through a decentralized, community-driven approach.

Hecla Mining Co. engages in the provision of precious and base metals. It operates through the following segments: Greens Creek, Lucky Friday, Keno Hill, Casa Berardi, and Other. The company was founded by Amasa B. Campbell, Patsy Clark, and John Finch on October 14, 1891 and is headquartered in Coeur d'Alene, ID.

Hecla Mining Co.

Hecla Mining is trending as discussions revolve around the potential impact of rising silver and gold prices on the company. Community members are also actively discussing Hecla's inclusion in the S&P SmallCap 600 index, which may lead to increased passive investment flows. Broader positive sentiment in the materials sector is also seen as a potential tailwind for the stock.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health ($HROW) is trending as investors discuss the potential impact of VEVYE's growth and upcoming catalysts like the investor day and Q3 report. The community is debating VEVYE's market position amid mixed patient reviews of Tryptyr, another dry eye treatment. Some are optimistic about potential acquisitions and the company's long-term growth prospects, while others focus on short interest and technical analysis.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

Binance's BNB.X is currently trending as the crypto community discusses its impressive rally and potential targets, including speculation about reaching $1000 soon. The recent partnership between Binance and Franklin Templeton to develop digital asset initiatives has also generated significant buzz. Discussions also involve the potential for Solana to surpass BNB.X in market capitalization.

Pump.fun

$PUMP.X is trending as the community highlights its position as a key player in the Solana meme coin ecosystem, with many pointing to the project's continued buybacks. Community members are actively discussing potential price targets and expressing excitement about its potential for significant gains in the current cycle. Some are calling it the 'NASDAQ of shit coins' and believe it will lead the altcoin season.

MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on the development and manufacturing of genetic medicines to treat both inherited and more common conditions with severe unmet need. The company was founded on March 20, 2015 and is headquartered in New York, NY.

MeiraGTx Holdings plc

MeiraGTx (MGTX) is trending following news of a strategic investment from Sanofi, with the community viewing this as a strong signal of confidence in the company's gene therapy platform and pipeline. Discussions revolve around potential implications for future partnerships, acquisitions, and the undervalued nature of MGTX relative to its assets. Optimism is fueled by upcoming catalysts and the potential for significant revenue growth.

Roundhill ETF Trust - Roundhill HOOD WeeklyPay ETF

HOOW is trending due to discussions surrounding its weekly dividend payouts, with investors comparing its performance against similar ETFs and strategies. The community is actively analyzing distribution amounts and strategizing around ex-dividend dates, while some are rotating into HOOW for its weekly compounding potential. There's also interest in Roundhill's potential new weekly ETFs.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu.X is trending as the community rallies around the project's strong fundamentals and growing holder base. Discussions highlight the unique aspect of Kendu as a brand coin with real-world applications, including Kendu Energy and Kendu beer. The community expresses excitement for upcoming catalysts and partnerships, reinforcing their long-term vision.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending as investors discuss its price action, citing frustration with recent performance despite positive fundamentals. Community members are debating accumulation zones and potential support levels, with some highlighting an upcoming earnings report and a supplemental Biologics License Application (sBLA) for label expansion as potential catalysts. Some are also speculating about potential M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pliant Therapeutics, Inc. (Pliant or the Company) (NASDAQ...

Buy Rating Affirmed for Pliant Therapeutics Amid Progress in IPF Treatment Trials

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Pliant Therapeutics (PLRX Research Report), boosting the price target to $38.00. Ed...

Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients

Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis...

Pliant Therapeutics to Participate in Upcoming Investor Events

SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel...

Pliant Therapeutics (PLRX, $14.81) entered Downtrend as Momentum indicator drops below 0 level on Apr 01, 2024

This indicator may be signaling that PLRX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Pliant Therapeutics (PLRX, $14.81) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that PLRX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Analysts Set Pliant Therapeutics, Inc. (NASDAQ:PLRX) Price Target at $48.44

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX - Get Free Report) have been assigned a consensus recommendation of "Buy" from the ten analysts that are currently covering the firm, Marketbeat.com...

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Current Price	$1.59
Prev Close	$1.65
Open	$1.67
Dividend Yield	0.00%
50-Day Moving Average	$1.55
Beta	1.28
Avg. Volume	1.01M
PE Ratio	-0.47

52-Week High	$16.10
52-Week Low	$1.10
Market Capitalization	$97.61M
EPS (Annual)	-$3.47
Price to Book	0.44
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PLRX
Pliant Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLRX News

PLRX Pliant Therapeutics Inc